Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Other Operating Expenses (2016 - 2021)

BioRestorative Therapies (BRTX) has disclosed Other Operating Expenses for 14 consecutive years, with -$932573.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to -$932573.0, compared with a TTM value of $932573.0 through Jun 2025, up 238.23%, and an annual FY2020 reading of $165531.0, down 92.59% over the prior year.
  • Other Operating Expenses was -$932573.0 for Q3 2025 at BioRestorative Therapies, down from $932573.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $932573.0 in Q2 2025 and bottomed at -$1.0 million in Q2 2024.
  • Average Other Operating Expenses over 4 years is -$69804.1, with a median of $7868.0 recorded in 2021.
  • The sharpest move saw Other Operating Expenses crashed 1667.92% in 2024, then skyrocketed 191.51% in 2025.
  • Year by year, Other Operating Expenses stood at -$18857.0 in 2021, then soared by 1926.91% to $344500.0 in 2023, then crashed by 395.83% to -$1.0 million in 2024, then rose by 8.49% to -$932573.0 in 2025.
  • Business Quant data shows Other Operating Expenses for BRTX at -$932573.0 in Q3 2025, $932573.0 in Q2 2025, and -$1.0 million in Q2 2024.